|
|
Memantine (Axura)
Substance developed by the Merz research organization used to treat dementia and Alzheimer's Disease.
Memantine - Wikipedia, the free encyclopedia
Although memantine is approved for treatment of moderate to severe Alzheimer's ... Memantine is also being tested for opioid dependence, systemic lupus ...
memantine (Namenda) - drug class, medical uses, medication side effects ...
Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe dementia of the Alzheimer's type.
Memantine: Information from Answers.com
Memantine Memantine is a new drug for treating Alzheimer's disease, mental confusion, forgetfulness, disturbances of short time memory and dementia
memantine.com - Brief Profile
Memantine is the first and only representative of a new class of Alzheimer drugs ... Memantine has been developed by Merz Pharmaceuticals and is approved in Europe ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... Memantine HCl occurs as a fine white to off-white powder and is soluble in water. ...
MEMANTINE
Memantine / Ebixa / Namenda ... But Memantine works very differently. ... Memantine may prevent this destructive sequence by filling the NMDA receptor sites. ...
Huntington's Disease Information - HOPES - Memantine, L5
As an NMDA antagonist, memantine prevents the neurotransmitter glutamate from ... Memantine has been clinically used to treat dementia and Alzheimer's disease. ...
Namenda (Memantine HCL) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Namenda (Memantine HCL), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
Memantine - Yahoo! Health
Before using memantine, tell your doctor if you are allergic to any drugs, or if ... What is the most important information I should know about memantine? ...
|
|
|
|
Memantines |
DEUTERIUM-ENRICHED MEMANTINE - Patent - The present application describes deuterium-enriched memantine pharmaceutically acceptable salt forms thereof
The present application describes deuterium-enriched memantine,
pharmaceutically acceptable salt forms thereof, and methods of treating
using the same., is selected from at least 5%, at least 10%,
at least 14%, at least 19%, at least 24%, at least 29%, at least 33%, at
least 38%, at least 43%, at least 48%, at least 52%, (k) at least 57%, at
least 62%, at least 67%, at least 71%, at least 76%, at least 81%, at
least 86%, at least 90%, at least 95%, and 100%.
The present invention is based on increasing the amount of deuterium
present in memantine above its natural abundance. This increasing is
called enrichment or deuterium-enrichment. If not specifically noted, the
percentage of enrichment refers to the percentage of deuterium present in
the compound, mixture of compounds, or composition.
|
Rating: 3.5 из 5 (голосов: 151) |
|
9 january 2008
Александр Кузнецов
|
|
|
|
|
memantina
donepezil and memantine
memantine chemical
memantina
|
|
|
|
|
|
|
|
|
|
|